Company Encyclopedia
View More
name
Phibro Animal Health
PAHC.US
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers.
4.514 T
PAHC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking22/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE23.79%A
    • Profit Margin4.85%C
    • Gross Margin33.22%C
  • Growth ScoreA
    • Revenue YoY33.71%A
    • Net Profit YoY289.61%A
    • Total Assets YoY43.39%A
    • Net Assets YoY20.56%A
  • Cash ScoreA
    • Cash Flow Margin2063.93%A
    • OCF YoY33.71%A
  • Operating ScoreA
    • Turnover1.19A
  • Debt ScoreE
    • Gearing Ratio77.50%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Chmn Bendheim Sells 7,040 ($288.6K) Of Phibro Animal Health Corp [PAHC]

    Chairman Jack C. Bendheim of Phibro Animal Health Corp (PAHC) sold 7,040 shares worth $288,606 as disclosed in a Form 4 filed with the SEC. The transaction was executed under a prearranged trading plan (10b5-1). Bendheim's remaining holdings are 66,600 shares.

    Reuters·
    US
    PAHC
    0.00%
    Reuters·
    US
    PAHC
    0.00%

    Owner BFI Co LLC Files To Sell 316,800 Of Phibro Animal Health Corp [PAHC]

    BFI Co LLC, a beneficial owner of Phibro Animal Health Corp, filed a Form 144 with the SEC to sell 316,800 shares on December 4, 2025. The sale will be executed through Goldman Sachs & Co under a prearranged trading plan (10b5-1). This filing allows the owner to sell the shares within 90 days.

    Reuters·
    US
    PAHC
    0.00%
    Reuters·
    US
    PAHC
    0.00%

    Chmn Bendheim Sells 12,320 ($541.7K) Of Phibro Animal Health Corp [PAHC]

    Chairman Jack C Bendheim of Phibro Animal Health Corp sold 12,320 shares worth $541,673, as disclosed in a Form 4 filed with the SEC. The transaction was executed under a prearranged trading plan (10b5-1). Bendheim's ending holdings are 50,680 shares, with 16,840 direct and 33,840 indirect.

    Reuters·
    US
    PAHC
    0.00%
    Reuters·
    US
    PAHC
    0.00%

    Phibro Animal Health (PAHC): Assessing Valuation After Strong Share Price Gains

    Phibro Animal Health (PAHC) has experienced significant share price gains, with a year-to-date return of nearly 97%. Despite a recent pullback, the stock is considered slightly overvalued at $40.81, above its fair value of $39.75. The company's growth is driven by the integration of Zoetis Medicated Feed Additive business, but future growth may slow. A DCF model suggests the stock is undervalued by 58%, indicating potential market oversight. Investors are advised to consider both growth prospects and risks.

    Simplywall·
    US
    PAHC
    0.00%
    Simplywall·
    US
    PAHC
    0.00%

    Chmn Bendheim Sells 10,560 ($466.6K) Of Phibro Animal Health Corp [PAHC]

    Bendheim Jack C, Chairman of Phibro Animal Health Corp, sold 10,560 shares valued at $466,631 as part of a prearranged trading plan (10b5-1). The transaction was disclosed in a Form 4 filed with the SEC on November 18, 2025. Following the sale, Bendheim's holdings are 66,520 shares, with 16,840 held directly and 49,680 indirectly.

    Reuters·
    US
    PAHC
    0.00%
    Reuters·
    US
    PAHC
    0.00%
    © 2025 Longbridge｜Disclaimer